US FDA approves AbbVie’s drug for Parkinson’s disease
On Sept. 25, 2026, the US Food and Drug Administration announced approval of AbbVie’s treatment for Parkinson’s disease…
-
-
Biotechnology | Disease | FDA | Therapeutics
FDA approves Lilly’s Onswik™, a once-weekly basal insulin injection treatment for adults with type 2 diabetes
On Sept. 24, 2026, Eli Lilly and Company announced the U.S. Food and Drug Administration (FDA) approval of Onswik™ (insulin…
-
SystImmune Receives FDA Clearance of IND Application for Bispecific Antibody SI-B037
On Sept. 23, 2026, SystImmune announces the U.S. Food and Drug Administration (FDA) has cleared its Investigational New…
-
Biotechnology | CDC | Chemistry | Clinical Research | Cosmetic | FDA | Infectious Disease | NIH | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics | U.S. Congress | Veterinary
HHS Accelerates Shift to Human-Based Research, Reduces Reliance on Animal Testing
On Sept. 21, 2026, the U.S. Department of Health and Human Services (HHS) announced a new wave of…
-
Biotechnology | FDA | Oncology
U.S. FDA approves Inluriyo (imlunestrant) in combination with Verzenio (abemaciclib) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer
On Sept. 18, 2026, Eli Lilly and Company announced that the U.S. Food and Drug Administration(FDA) has granted…
-
Ultragenyx Announces Approval of FAYUVI™ Gene Therapy, the First-Ever FDA-Approved Treatment for Sanfilippo Syndrome Type A
On Sept. 17, 2026, Ultragenyx Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) granted standard full…
-
FDA Approves Bayer’s KERENDIA® (finerenone) as First New Treatment in 30 Years for Adults with Chronic Kidney Disease and Type 1 Diabetes
On Sept. 17, 2026, Bayer announced that the U.S. Food and Drug Administration (FDA) approved KERENDIA® (finerenone) to…
-
CDC | EPA | FDA | NIH | Non-Profit Research | U.S. Congress | USDA | WHO
Lost Funds Project Tracks $177.5 Billion in federal funding disruptions and their impacts by state
On Sept. 16, 2026, The Lost Funds Project, a comprehensive resource tracking federal funding disruptions and their impacts…
-
Biotechnology | FDA | Medical Device | Oncology | Organoids | Pharmaceutical | Rare Disease | Robotics | Stem Cell | Telemedicine | Therapeutics | Vaccine | Women's Health
FDA Launches Expedited IND Pilot Program, Begins Accepting Applications
On Sept. 15, 2026, the U.S. Food and Drug Administration announced the final design of the Expedited Investigational…
-
Paradromics Achieves Real-Time Speech with Connexus® Brain-Computer Interface
On Sept. 14, 2026, Paradromics, a neurotechnology company developing a high-data-rate brain-computer interface (BCI) platform designed to restore…
-
Biotechnology | FDA | Imaging | Neurology
FDA Approves Telix’s Brain Cancer Imaging Drug Pixclara
On Sept. 14, 2026, Telix today announces that the U.S. Food and Drug Administration (FDA) has approved its…
-
Abbott receives FDA approval for its TactiFlex™ Duo Ablation Catheter to treat people with abnormal heart rhythms
On Sept. 8, 2026, Abbott announced it has received U.S. Food and Drug Administration (FDA) approval for the…
-
FDA Grants Accelerated Approval to AstraZeneca’s New Breast Cancer Treatment
On Sept. 4, 2026, the U.S. Food and Drug Administration (FDA) announced they have expanded treatment options for…
-
ZANVASTRO™ (zilganersen) approved by the FDA as the first and only disease modifying treatment for Alexander disease (AxD) in pediatric and adult patients
On Sept. 3, Ionis Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved ZANVASTRO™ (zilganersen)…
-
Biotechnology | Disease | FDA
Roivant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis
On Aug. 27, 2026, Roivant announced that the U.S. Food and Drug Administration (FDA) has approved LISRAYA™ (brepocitinib)…
-
Biotechnology | FDA | HIV
U.S. FDA Approves Gilead’s Bixlenvo™, a Once-Daily Single Tablet Option for Virologically Suppressed Adults With HIV
On Aug. 27, 2026, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) approved Bixlenvo™ (bictegravir…
-
Biotechnology | FDA | Oncology
FDA approves new pancreatic cancer drug Offering new treatment
On Aug. 26, 2026, the U.S. Food and Drug Administration (FDA) approved Rasonque (daraxonrasib), a RAS inhibitor for…
-
FDA approves Johnson & Johnson’s IMAAVY® as first-ever treatment for warm autoimmune hemolytic anemia, a landmark advancement
On Aug. 24, 2026, Johnson & Johnson announced the U.S. Food and Drug Administration (FDA) approval of IMAAVY®…
-
Roche receives FDA clearance for Elecsys® pTau217, advancing Alzheimer’s disease assessment across primary and specialty care
On Aug. 24, 2026, Roche announced that the U.S. Food and Drug Administration (FDA) has cleared the Elecsys®…
-
Diagnostics | FDA | Medical Device | Robotics
FDA Authorizes First-Of-Its-Kind Robotic Blood Draw Device
On Aug. 19, 2026, the U.S. Food and Drug Administration (FDA) announced it has authorized the Aletta, the…
-
Tattoo Ink Might Not Be as Sterile as You Think, According to the FDA
On Aug. 13, 2026, the U.S. Food and Drug Administration (FDA) has confirmed the findings of previous studies…
-
FDA approves Moderna’s New mRNA-based influenza vaccine for adults
On Aug. 6, 2026, the Food and Drug Administration announced it has approved a new kind of flu…
-
U.S. FDA Approves Takeda’s ORZEYFUL™ , the First and Only Medicine to Treat Narcolepsy
On Aug. 5, 2026, Takeda announced that the U.S. Food and Drug Administration (FDA) had approved ORZEYFUL™ (oveporexton),…
-
Biotechnology | FDA | Oncology
FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease
On Jul. 31, 2026, Novartis announced the US Food and Drug Administration (FDA) approved Pluvicto® (lutetium Lu 177…
-
FDA Licenses First-Ever Freeze-Dried Plasma Product in the U.S.
On Jul. 29, 2026, the U.S. Food and Drug Administration (FDA) announced it has licensed Ezplaz Freeze Dried…
-
Biotechnology | Diagnostics | FDA | Oncology
FDA Approves SimpleScreen CRC Blood Test for Colorectal Cancer Screening
On Jul. 28, 2026, The U.S. Food and Drug Administration (FDA) announced it had approved SimpleScreen™ CRC, a…
-
Agriculture | Biotechnology | CDC | Diagnostics | Disease | FDA
Michigan reports 9,253 cyclosporiasis cases as infection outbreak expands
On Jul. 27, 2026, Michigan health officials reported 9,253 cases of cyclosporiasis, an increase of 1,077 cases since…
-
FDA Approves Tylenol Nonprescription Fixed-Dose Combination of Acetaminophen and Naproxen Sodium for 12-Hour Pain Relief
On Jul. 24, 2026, U.S. Food and Drug Administration (FDA) approved Tylenol with Naproxen (acetaminophen 325 mg/naproxen sodium…
-
Otsuka Receives FDA Approval for First-in-Class SIMTRIYO® (centanafadine) for Treatment of ADHD
On Jul. 24, 2026, Otsuka Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has granted approval…
-
U.S. FDA investigates another cyclosporiasis outbreak
On Jul. 22, 2026, The U.S. Food and Drug Administration (FDA) announced it is investigating a new outbreak…
